| Doxycycline, an inhibitor of mitochondrial biogenesis, effectively reduces cancer stem cells (CSCs) in early breast cancer patients: a clinical pilot study C Scatena, M Roncella, A Di Paolo, P Aretini, M Menicagli, G Fanelli, ... Frontiers in oncology 8, 452, 2018 | 119 | 2018 |
| Molecular mechanisms, biomarkers and emerging therapies for chemotherapy resistant TNBC P Ferrari, C Scatena, M Ghilli, I Bargagna, G Lorenzini, A Nicolini International journal of molecular sciences 23 (3), 1665, 2022 | 92 | 2022 |
| Overexpression of TK1 and CDK9 in plasma-derived exosomes is associated with clinical resistance to CDK4/6 inhibitors in metastatic breast cancer patients M Del Re, I Bertolini, S Crucitta, L Fontanelli, E Rofi, C De Angelis, ... Breast Cancer Research and Treatment 178, 57-62, 2019 | 78 | 2019 |
| Circulating tumor cells detection and counting in uveal melanomas by a filtration-based method C Mazzini, P Pinzani, F Salvianti, C Scatena, M Paglierani, F Ucci, ... Cancers 6 (1), 323-332, 2014 | 67 | 2014 |
| Cutaneous melanoma classification: the importance of high-throughput genomic technologies C Scatena, D Murtas, S Tomei Frontiers in oncology 11, 635488, 2021 | 66 | 2021 |
| Immunohistochemistry is highly sensitive and specific for the detection of NRASQ61R mutation in melanoma D Massi, L Simi, E Sensi, G Baroni, G Xue, C Scatena, A Caldarella, ... Modern Pathology 28 (4), 487-497, 2015 | 66 | 2015 |
| Decipher the glioblastoma microenvironment: the first milestone for new groundbreaking therapeutic strategies GN Fanelli, D Grassini, V Ortenzi, F Pasqualetti, N Montemurro, P Perrini, ... Genes 12 (3), 445, 2021 | 62 | 2021 |
| A mouse mammary tumor virus env-like exogenous sequence is strictly related to progression of human sporadic breast carcinoma CM Mazzanti, M Al Hamad, G Fanelli, C Scatena, F Zammarchi, ... The American journal of pathology 179 (4), 2083-2090, 2011 | 52 | 2011 |
| Surgical outcome and molecular pattern characterization of recurrent glioblastoma multiforme: A single-center retrospective series N Montemurro, GN Fanelli, C Scatena, V Ortenzi, F Pasqualetti, ... Clinical Neurology and Neurosurgery 207, 106735, 2021 | 48 | 2021 |
| Human saliva as route of inter-human infection for mouse mammary tumor virus CM Mazzanti, F Lessi, I Armogida, K Zavaglia, S Franceschi, M Al Hamad, ... Oncotarget 6 (21), 18355, 2015 | 48 | 2015 |
| Detection of circulating tumor cells in patients with adrenocortical carcinoma: a monocentric preliminary study P Pinzani, C Scatena, F Salvianti, E Corsini, L Canu, G Poli, M Paglierani, ... The Journal of Clinical Endocrinology & Metabolism 98 (9), 3731-3738, 2013 | 48 | 2013 |
| Micro-RNA-21 (biomarker) and global longitudinal strain (functional marker) in detection of myocardial fibrotic burden in severe aortic valve stenosis: a pilot study I Fabiani, C Scatena, CM Mazzanti, L Conte, NR Pugliese, S Franceschi, ... Journal of translational medicine 14, 1-11, 2016 | 47 | 2016 |
| Bedaquiline, an FDA-approved drug, inhibits mitochondrial ATP production and metastasis in vivo, by targeting the gamma subunit (ATP5F1C) of the ATP synthase M Fiorillo, C Scatena, AG Naccarato, F Sotgia, MP Lisanti Cell Death & Differentiation 28 (9), 2797-2817, 2021 | 40 | 2021 |
| Sparc-like protein 1 is a new marker of human glioma progression A Turtoi, D Musmeci, AG Naccarato, C Scatena, V Ortenzi, R Kiss, ... Journal of proteome research 11 (10), 5011-5021, 2012 | 40 | 2012 |
| Pre-operative management of pleomorphic and florid lobular carcinoma in situ of the breast: report of a large multi-institutional series and review of the literature MP Foschini, R Miglio, R Fiore, C Baldovini, I Castellano, G Callagy, ... European Journal of Surgical Oncology 45 (12), 2279-2286, 2019 | 37 | 2019 |
| New insights in the clinical and translational relevance of miR483-5p in adrenocortical cancer F Salvianti, L Canu, G Poli, R Armignacco, C Scatena, G Cantini, ... Oncotarget 8 (39), 65525, 2017 | 37 | 2017 |
| Recent advances in cancer plasticity: cellular mechanisms, surveillance strategies, and therapeutic optimization GN Fanelli, AG Naccarato, C Scatena Frontiers in Oncology 10, 569, 2020 | 36 | 2020 |
| Biomarkers for precision immunotherapy in the metastatic setting: hope or reality? E Sajjadi, K Venetis, C Scatena, N Fusco Ecancermedicalscience 14, 2020 | 33 | 2020 |
| Impact of recurrence pattern in patients undergoing a second surgery for recurrent glioblastoma F Pasqualetti, N Montemurro, I Desideri, M Loi, N Giannini, G Gadducci, ... Acta Neurologica Belgica, 1-6, 2022 | 32 | 2022 |
| Molecular characterization of low grade and high grade bladder cancer A Apollo, V Ortenzi, C Scatena, K Zavaglia, P Aretini, F Lessi, ... PLoS One 14 (1), e0210635, 2019 | 29 | 2019 |
